Study of High-dose Letrozole Therapy in Postmenopausal Patients With Breast Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

June 30, 2001

Primary Completion Date

October 31, 2006

Study Completion Date

October 31, 2006

Conditions
Postmenopausal Women With Advanced Breast Cancer
Interventions
DRUG

Letrozole

Trial Locations (12)

277-8577

Novartis Investigative Site, Kashiwa

791-0280

Novartis Investigative Site, Matsuyama

963-8501

Novartis Investigative Site, kooriyama

371-8511

Novartis Investigative Site, Maebashi

701-0192

Novartis Investigative Site, Kurashiki

338-8553

Novartis Investigative Site, Kitaadachi-gun

Novartis Investigative Site, Saitama

113-8677

Novartis Investigative Site, Bunkyo-ku

104-0045

Novartis Investigative Site, Chuo-ku

160-8582

Novartis Investigative Site, Shinjuku-ku

960-1295

Novartis Investigative Site, Fukushima

537-8511

Novartis Investigative Site, Osaka

Sponsors
All Listed Sponsors
collaborator

Chugai Pharmaceutical

INDUSTRY

lead

Novartis Pharmaceuticals

INDUSTRY